Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials. Even so, ...

Key Points CRISPR Therapeutics is still in its early growth stage.Summit Therapeutics has plenty of upside potential ...

Dividend stocks are a useful source of extra income. The best dividend stocks, however, also increase payouts over time and ...

J&J's stock price is down from its 2022 peak, but it's performed better than you might think by simply looking at its chart.

Pharmaceutical manufacturing in the U.S. has declined sharply over recent decades, with most active ingredient production shifting overseas due to lower labor costs. In 2023, the U.S.

The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 ...

Key Points Alibaba is a Chinese AI stock that's dirt cheap. Meta Platforms is making a huge bet on AI that should pay off ...

Key Points Pfizer and Novo Nordisk have underperformed the market over the past year.But both should remain major players in ...

In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $470.13, denoting a +2.54% move from the preceding trading day.

While both stocks are risky, Bausch Health is seeing operational momentum, while Canopy Growth is still struggling with ...

Stock Market Today: Indian equities rebounded strongly on Tuesday, 15 July, snapping a four-day losing streak as broad-based ...

Medtronic is a medical device powerhouse closing in on Dividend King status. Merck is a high-yield pharmaceutical giant with ...